The time-dependent release of prostaglandin E2 (PGE2), prostaglandin F2u (PGF2u), thromboxane (Tx) B2, and 6-keto-PGF)u (6-keto) from brain was measured before, during, and after a I5-min interval of total isch emia (four-vessel occlusion) in halothane-anesthetized cats using the technique of cerebroventricular perfusion. Resting levels of PGE2, PGF2u, 6-keto, and Tx were: 253 ± 75,953 ± 300, 650 ± 200, and 550 ± 170 pg/ml, re spectively. During the I5-min ischemia, all prostanoids rose significantly, yet the highest levels were not ob served until the first 15-60 min of the reflow at which time levels of PGE2, PGF2u, 6-keto, and Tx, as compared with the preischemic baseline, rose � 8 , 3.4, 3, and 55fold, respectively. Significantly, although all prostanoids showed increases relative to baseline, the ratios of PGF2u/6-keto and PGE2/6-keto remained stable throughout the experiment in both groups of animals. In
Immediately after the initiation of cerebral an oxia or ischemia there is a time-dependent increase in the brain levels of free fatty acids in general and the 20:4 form (arachidonic acid) in particular (Bazan, 1970; Rehncrona et ai., 1982; Siesjo and Wieloch, 1983; Wieloch and Siesjo, 1981; Yoshida et aI., 1980) . The increase in free arachidonic acid in the cytosol provides the substrate for the syn thesis by membrane bound cyclooxygenase of the prostanoid family.
Due to the effects of prostaglandin synthesis inhi bition and the bioactivity of several prostaglandins as regards vasomotor tone, capillary permeability contrast, the Tx/6-keto ratio rose from � 1 to � 30 during the 60 min after retlow in untreated cats. Tr eatment with zomepirac sodium (5 mg/kg, i.v.), a cYclooxygenase in hibitor, resulted in highly significant reductions in the levels of all prostanoids during the preischemic period. In zomepirac sodium-treated animals, there were also highly significant reductions in the prostanoid response to ischemia. Of particular interest was that the degree of inhibition of Tx as compared with 6-keto, during the post ischemic period of peak secretion was such that the Tx/6keto ratio fell from 30 in the control ischemic animal to 0.3 in the zomepirac sodium-treated animal, suggesting a selective blockade of the formation of Tx as compared with prostacyclin. Key Words: Cerebral ischemia, effect on prostaglandins release and cyclooxygenase inhibition -Prostacyclin, in brain-Thromboxane, in brain. and neuronal depression (see for example, Pickard, 1981; Forstermann et aI., 1982) , it has been pro posed that these products of arachidonic acid me tabolism may in part be responsible for physiologic changes seen after discrete periods of cerebral isch emia . Such changes include: (a) the initial postisch emic hyperemia, and the delayed hypoperfusion (Olsen and Larsen, 1981; Rehncrona et aI., 1979; Siesjo, 1981 Siesjo, , 1984 ; (b) the loss of cerebrovascular responsiveness (Kuwashima et aI., 1978; Siesjo, 1984; Ta kagi et ai., 1977; Stevens et ai., 1986) ; and (c) cerebral edema (Black et ai., 1984; Shohami et ai., 1987; Siesjo, 1981 Siesjo, , 1984 .
Interpretation of the potential role of prosta glandins in the ischemic event, however, is ren dered complex for several reasons. First, the sev eral members of the cyclooxygenase cascade pro duce a variety of effects-many of which effects are physiologically opposed. For instance, in creased levels of arachidonic acids will lead to the synthesis of both thromboxane and prostacyclin a powerful vasoconstrictor and vasodilator, respec tively (Gryglewski et aI. , 1983; Jacobs et aI., 1986; Moncada, 1983; Moncada and Vane, 1979; Mon cada et aI., 1980; Moskowitz and Coughlin, 1981; Pickard, 1981; Siesjo and Nilsson, 1982) . It is thus possible that the effects of increased cyclooxy genase activity may result from differential rates of synthesis of these products. The beneficial effects of cyclooxygenase inhibition noted above may thus arise from differential preservation of residual levels of one of the several products. Indeed, many cyclooxygenase inhibitors at doses or concentra tions that diminish thromboxane may have only marginal effects on prostacyclin in brain (Shohami et aI., 1982) or plasma (Moncada and Vane, 1978) .
Second, a variety of studies have demonstrated during ischemia the increase in prostanoid levels in cerebral tissue (Black et aI., 1984; Crockard et aI., 1982; Levine, 1979, 1980) . Given, how ever, that it is probable that the physiologic effects of prostanoids are mediated by action on other neu ronal elements and the cerebral vasculature, it is reasonable to query the levels and time course of the appearance of these products in the extravas cular-extracellular space. Importantly, in our pre vious work with cyclooxygenase inhibition, we ob served that the improved vascular and EEG status was correlated with pronounced reduction in the levels of prostaglandins in the brain extracellular spaces, as indicated by sampling of the cisternal CSF 2 h after a IS-min period of total ischemia (Stevens et aI., 1986) .
Third, it is anticipated that the release of pros tanoids secondary to ischemia will be temporally complex. Thus, although an increase in the levels of free fatty acids may occur at the onset of and continue unabated during the ischemic interval (Bazan, 1970; Pickard, 1981; Rehncrona et aI., 1982; Yoshida et aI., 1980 Yoshida et aI., , 1986 , the formation of the cyclooxygenase products is dependent on the presence of molecular oxygen (Gaudet et aI., 1980; Kemski et aI., 1987; Pickard, 1981; Siesjo and Nilsson, 1983) . It is probable that although pros tanoid synthesis may also begin at time of ischemia, it may be inhibited as cellular O2 is depleted. It would thus be anticipated that synthesis would be reinstated during the reflow phase when molecular oxygen again becomes available, and levels of ara chidonic acid are elevated. In addition, we have no reason to believe that the time course of appear ance of the several prostanoids will necessarily be the same. It would thus appear to be of advantage to follow the concurrent secretion of several pros tanoids over time before, during, and after isch emia. To date, experiments sampling tissue levels have by necessity measured prostanoid levels at discrete times in different groups of animals (Black et aI., 1984; Crockard et aI., 1982; Gaudet et aI., 1980; Jacobs et aI., 1986; Kemski et aI., 1987) .
To study the temporal fluctuation of prosta glandin E2 (PGE2), prostaglandin F2a (PGF2a), 6keto-PGFJa [the stable metabolite of prostaglandin 12 (PGI2), prostacyclin], and TxB2 (the stable me tabolite of thromboxane A2), before, during and after 15 min of global ischemia, we initiated studies using our previously documented feline model of ischemia (Stevens et aI., 1986) and the technique of cerebroventricular perfusion. These studies were carried out in both untreated animals and animals pretreated with zomepirac sodium, a well-defined cyclooxygenase inhibitor (Stevens et aI., 1986) .
METHODS

General preparation
Ten cats (male or female) weighing 3-5 kg were fasted 12-18 h before experimentation, with free access to water. After induction of anesthesia with 4% halothane and O2, a tracheal tube was inserted and the surgical preparation was carried out under 1.5-2.0% halothane. Halothane (1 %) delivered in an 02/air/C02 mixture (1.0:5.0:0.02) was used for maintenance during the re mainder of the experiment. Pancuronium bromide (0.15 mg i. v.) was used to achieve initial muscle paralysis, fol lowed by smaller periodic doses as needed to maintain muscle paralysis after the animal was started on a Har vard respirator. The right femoral artery and vein were cannulated to monitor blood pressure, obtain sequential samples for blood gases, and administer drugs. The left femoral artery was additionally catheterized to permit the withdrawal of blood while monitoring the MABP. Arterial blood gases and pH were measured with a Radiometer (PHM-73, Copenhagen) blood gas analyzer, and hemato crit was assessed periodically. Rectal temperatures were monitored and the animals were maintained at nor mothermia by use of an underbody heating blanket.
Ischemia
To permit the rapid induction of a reversible complete cerebral ischemia, the omocervical, internal thoracic, and vertebral arteries were identified via a trans axillary approach with use of an Olympus (Olympus Optical Co. Ltd., Japan) operating microscope and occluded bilater ally with a bipolar cautery. This eliminated all blood flow to the head except that from the carotid arteries and the small amount supplied by the spinal arterial cascade (Hossman et aI., 1976) . The carotid arteries were then exposed, with care taken to avoid distortion of the adja cent vagal nerve; silk ligatures were loosely places around each artery. The surgical procedure required 120 min to perform. To induce ischemia, the MABP of the animals was lowered to -80 mm Hg by the withdrawal of arterial blood via a heparinized syringe and occluding the carotid arteries with aneurysm clips placed on each. The jaws of these clips had sufficient pressure to eliminate blood flow through the carotid artery without visibly damaging it when removed. Examination of the EEG re vealed no change during the brief interval of hypotension before occlusion, but a complete loss of activity within 10-15 s of the placement of the aneurysm clips. The com pleteness of the ischemia in this model as we performed it has been shown by direct measurement of CBF using 133Xe clearance method (Stevens et aI., 1986) .
Ventricular perfusion
For ventricular perfusion, a 20-gauge stainless steel cannula was carefully and stereotactically placed into the right lateral ventricle. Artificial CSF (pH = 7.3) was in fused via the right ventricular catheter by a peristaltic pump and retrieved from a cisterna magna cannula at a constant rate of -100 J..L lImin. To avoid undue trauma ar tifact due to cannula insertion, animals were not used if a patent ventricular infusion was not achieved in the first attempt. Animals that had evident blood in the CSF per fusate retrieved from the cisterna magna cannula were also excluded from the study.
EEG
To monitor EEG activity, five parasagittal I-mm drill holes were made bilaterally along with a vertex skull hole. Ten gold-plated pins were placed in these holes and 1O-channel EEG monitoring was carried out with a Grass model 6-electroencephalograph (Grass Instrument Co., Quincy, MA, U.S.A.). EEG recordings were graded be fore, during, and after ischemia on a scale of 1-6 as de scribed in our previous paper (Stevens et aI., 1986) .
Prostanoid measurement
PGE2, PGF2a, 6-keto-PGF1a (the stable metabolite of PGI2, prostacyclin), and TxB2 were extracted, concen trated, and measured via radioimmunoassay as described in detail previously (Romero et aI., 1984) . The absolute sensitivity of each of the assays was 2.5-4, 3-4, 2.5-5, and 1.5-3 pg/ml of CSF, respectively.
Drug
Zomepirac sodium ([5-(4-chlorbenzoyl)-I,4-dimethyl [lH]pyrrole-2-acetate dihydrate sodium)), was obtained from McNeil Laboratories (Fort Washington, PA, U.S.A.). It is freely soluble in saline and is a potent inhib itor of cyclooxygenase (Pruss et aI., 1980; Romero et aI., 198 1; Stevens et aI., 1986) .
Experimental design
The experimental sequence consisted of surgical prep aration (-120 min) and the injection of drug (or saline), collection of three preischemic 30-min perfusion samples, initiation of the I5-min period of ischemia (during which three 5-min perfusion samples were collected), reflow for 2 h (during which three 5-min, followed by three 15-min, followed by two 30-min perfusion samples were col lected), and then killing of the animal. The three 30-min preischemic perfusion samples were taken to allow equil ibration of prostanoid levels. Therefore the prostanoid measurements of the third preischemic sample were taken as the resting (baseline) level of each prostanoid. This period was derived based on previous work sug gesting that after this initial interval of stabilization, the levels of prostanoids remained stable during subsequent perfusion in the absence of any manipulation (unpub lished observations; Navarro et aI., 1988) .
Two groups of five cats each were used to elevate the temporal changes in the synthesis of PGE2, PGF2a, 6- 1988 keto-PGF1a, TxB2, and recovery of EEG. Both groups were subjected to a IS-min period of reversible complete global ischemia and 2 h of reflow. Group 1 animals were untreated. Group 2 animals received zomepirac sodium pretreatment (5 mg/kg, i. v.) 1 h before completion of sur gical preparation.
Reversible complete cerebral ischemia was induced as described above for 15 min. Reflow was established by reinfusion of blood through the right femoral vein cath eter -30 s before the end of the IS-min ischemic period and removal of the aneurysm clips from the carotid ar teries.
Assessment of functional recovery was via monitoring of EEG temporal evolution during the 2-h reflow phase. Grading of EEG was performed in a similar manner as described previously (Stevens et aI., 1986) .
Statistics
Data are presented as means ± SE or as percentage change from baseline. Comparisons before and after treatment were carried out using a one-way repeated measures analysis of variance. In the case of individual comparisons for pre-and postischemia, paired t tests were employed.
RESULTS
Preischemia prostanoid levels
Figures 1 and 2 demonstrate the mean ± SE levels of PGE2, PGF2a, thromboxane B2 and 6keto-Fl U in the 14 CSF perfusate sampling periods for both zomepirac sodium pretreated and un treated cats.
Ta ble 1 presents the mean resting levels in con trol and zomepirac sodium-treated cats of the four prostanoids measured in the third perfusion sample obtained immediately before ischemia (baseline). As indicated, in control animals resting levels rela tive to 6-keto were: PGF2a (1.47 ± 0.5), 6-keto 0), Tx (0. 85 ± 0. 2), PGE2 (0.39 ± 0.15) (fl ± SE; n = 5). After zomepirac sodium, there was a uniform, highly significant reduction in the baseline levels of all prostanoids. Thus, as shown in Table 1 , and in Figs. 1 and 2, there is nearly a 4, 15, 7, and 3.5-fold reduction in the levels of PGE2, PGF2a, 6-keto, and Tx, respectively. The basal levels of those pros tanoids in the perfusate of the zomepirac sodium treated cats relative to 6-keto were: PGF2a (1. 65 ± 0.6), 6-keto (1), PGE2 (0. 69 ± 0.25), and Tx (0.66 ± 0.3). There was no statistical difference in the levels of the three prostanoids relative to 6-keto in the preischemic perfusate from the control zome pirac sodium-treated cats (p < 0.20).
Postischemia prostanoid levels
In untreated animals, during the first 10 min after the onset of ischemia, all prostanoids except PGF2a showed statistical increases in their CSF levels (p < 0.05). The ordering of increase at the end of the IS-min ischemic period, immediately preceding re- flow, was Tx (1S.6 ± 2. I-fold); PGE2 (S.6 ± 1.4fold), 6-keto (1.7 ± O.S-fold), PGF2o. (0.96 ± 0.2fold), as compared with the preischemic baseline sample.
In spite of these increases during ischemia, Figs. 1 and 2 indicate that the maximum increase for all prostaglandins was observed during the reflow pe riod in both groups of cats. Thus, PGE2, PGF2o.' and 6-keto attained their maximum elevation during the first IS min of reflow in untreated animals 7.6 ± 2.1, 3. 4 ± 1.6, and 3 ± 1, over the preischemic baseline, respectively (p < 0.01). Thromboxane reached its maximum elevation during the 60-7S min sampling interval (S4.S ± 9.6-fold over base line). These peak values for all prostanoids ob served during reflow were statistically greater than levels observed at the end of the ischemic interval (p < 0.01).
After 2 h of reflow all prostanoids continued to show significant elevation from baseline although significantly reduced from their maximum, in the untreated group. Examination of the last sampling Note that in the thromboxane graph the right y-axis only ap plies to zomepirac sodium-pretreated animals and the left y-axis applies only to untreated ones. period shows that PGE2, PGF2o.' 6-keto, and Tx re main elevated at �2. 4, 2.4, 1. 7S, and 27 times base line, respectively (p < O.OS).
Although similar trends were observed in the zo mepirac sodium-pretreated group as were seen in the untreated cats, e.g., the major rise of the pros tanoids occurred during the reflow period, as shown in Figs. 1 and 2 , the response was very much attenuated. Thus, the maximum increases relative to baseline observed during reflow for Tx, 6-keto, PGF2o.' and PGE2 in zomepirac sodium-treated cats were 2.2 ± 0.7, 4 ± 1.7, 3. S ± 1. 2, and 2.9 ± 1. 1fold, respectively. These increases reached statis tical significance for 6-keto (p < O.OS).
Relative prostanoid levels Figure 3 shows the mean ratio of PGE2, PGF2o.' and TxB2 to 6-keto during each of the 14 sampling periods. Preischemically, Tx levels relative to 6keto, in both untreated and treated animals was � 1, indicating their uniform reduction by cyclooxy genase inhibition. During ischemia in untreated an imals, although all prostanoid levels rose, the Tx/6- keto ratio approached 30 after �60 min of reflow. The uniqueness of this response of Tx to ischemia is emphasized by the relative stability of the PGE2/6-keto and PGF2,/6-keto ratios (Fig. 3A and B: p < 0.20; t test, greatest ordered difference). In the zomepirac sodium-treated group after ischemia, the prominent increase in the Tx/6-keto ratio was not observed. Indeed, there was marked reduction, such that at �60 min of reflow, the ratio was 0. 3 (p < 0. 05 as compared with baseline).
EEG
The characteristics of the EEG observed in re sponse to drug and ischemia in the present studies were identical to that previously described using this model (Stevens et aI., 1986) . In brief, all cats displayed a normal resting pattern expected in a 1 minimum aveolar concentration (MAC) halothane anesthetized cat. Zomepirac sodium had no effect. Mter occlusion, EEG tracings became isoelectric in all animals (grade 6) within 10-15 s. Immediately after reflow, all five untreated cats were given an EEG grade of 6. Three zomepirac sodium-pre treated cats were graded as 6, and two were graded as 5. At the end of the 2-h reflow period, four of five untreated animals were given a score of 5 and the other were given a grade of 4. As for zomepirac sodium-pretreated cats, four cats were grade 1 and the other a grade 0 after 2 h of reflow.
DISCUSSION
Under control conditions, in the absence of phar macological or physiological manipulations, the basal secretion of cyclooxygenase products into cerebroventricular perfusates remains stable and low, yet measurable in the anesthetized cat (Ro mero et aI., 1984; Navarro et aI. , 1988; present study) . In the present studies, after the onset of ischemia, the levels of PGE2, 6-keto-PGF1 n , and TxB2 in the extravascular-extracellular space ini tially rose precipitously, but all, including PGF2 n , reached their maximum during the reflow phase. Although CBF measurements were not performed in these studies, our previous work employing J Cereb Blood Flow Metab, Vol. 8, No.6, 1988 xenon clearance emphasized that ligation of the ca rotids and vertebrals in conjunction with mild hy potension results in a complete loss of xenon clear ance and a rapid 00-15 s) flattening of the EEG (Stevens et aI., 1986) . During reperfusion, blood flow displayed an initial hyperemia that lasted for �20-30 min followed during the next 1 V2 h by a hypoperfusion. In our previous study (Stevens et aI., 1986) untreated animals not only experienced profound hypoperfusion, but little or no EEG re covery was observed. In contrast, zomepirac so dium-pretreated cats experienced little or no de layed hypoperfusion, and had EEG recovery to near preischemic patterns. In the present study a similar EEG profile was observed.
Origin of CSF prostaglandins
Measurement of prostaglandins in brain slices and cell cultures has demonstrated that a variety of stimuli can give rise to increased levels of cycloox ygenase products in the preparation, suggesting that these lipidic acids may be formed in the paren chyma (Willis et aI., 1972; Wolfe et aI., 1976) . Nev ertheless, for Tx and prostacyclin, it appears that a significant source is the platelet and endothelial cell, respectively (Moncada and Vane, 1979) . The probability that these sources could contribute to the levels observed in the present ventriculocis ternal perfusates cannot be excluded. In any case, the present experiments indicate that whatever their source, these lipidic acids may rise to promi nent levels in the extravascular-extracellular space of the brain.
An important question relates to the extent to which the levels of prostanoids in the perfusate de rive from trauma induced by the preparation. The appearance of blood or the generation of multiple ventricular punctures will lead to marked increases in measured prostanoid levels (unpublished obser vations). For that reason, strict exclusion criteria were employed to ensure that all animals were as identical as possible. The fact that during the three preischemic 30-min sampling periods, levels of PGE2, TxB2, and 6-keto decline asymptotically may reflect the effects of the preparation. Never- theless, it is clear that the marked elevation in ex travascular-extracellular levels of these lipidic acids occurred secondary to events generated by an ischemic insult.
Mechanism of augmented secretion of eNS prostaglandins
The movement of lipidic acids into the extravas cular-extracellular space after ischemia likely re-flects the acute increase during ischemia of the levels in brain of a variety of free fatty acids with the principal component being the arachidonate (Kuwashima et aI. , 1978; Yoshida et aI. , 1986; Gar diner et aI. , 1981; Rehncrona et aI. , 1982) . The in creased level of intracellular free fatty acids can occur by several mechanisms, all of which may be affected by ischemia. These include (a) the well known activation of phospholipase A2 secondary to an increase in the levels of cytosolic Ca 2 +; (b) by activation of plasmalogenase and lypophospholi pase (Horrocks et aI. , 1978) ; and/or (c) by catabo lism of phosphoinositides (Sun et aI. , 1979) . With regard to the first mechanism, increased levels of intracellular Ca 2 + that appear to occur after isch emia (Harris et aI. , 1981; Hossman et aI., 1983; Dienel, 1984) may result from (a) the opening of voltage-sensitive channels (N owycky et aI. , 1985) • as the cell loses its ability to maintain the transmembrane gradients for Na + and K + leading to cell depolarization (Astrup et aI. , 1977) ; (b) the activa tion by receptor-linked Ca 2 + channels such as those thought to be opened by glutamate through an N-methyl-D-aspartate-linked receptor (Dingle dine, 1983) ; and (c) failure of mitochondrial seques tration of Ca 2 + (Nicholls and Akerman, 1982; Siesjo, 1981 Siesjo, , 1984 and the cessation of the active export of Ca 2 + by antiporter mechanisms. With re gard to the membrane phosphoinositides, their ca tabolism can be activated by a variety of neuro transmitters including acetylcholine and noradrena line (Berridge, 1984) . In this regard, increased neurotransmitter secretion from neural terminals can occur as a consequence of increased neuronal activity and/or by depolarization secondary to re gional energy failure. Indeed, increased glutamate release has been postulated to be an important me diator of the neuronal damage observed secondary to seizures and ischemia (Rothman and Olney, 1986) . Increased free fatty acid levels are known to occur in brain during chemical and electrically in duced seizures (Bazan, 1970 (Bazan, , 1976 . In previous work, we have observed that direct depolarization by veratridine or 40 mM K + or indirect activation with strychnine, bicuculline, or pentylenetetrazol (Romero et aI. , 1984; Navarro et aI. , unpublished data) will evoke prominent, stimulus-dependent in creases in cyclooxygenase products. This is consis tent with a depolarization mediated mechanism of mobilizing free fatty acid pools necessary for CNS prostanoid synthesis. In addition, however, appli cation of agonists for cholinergic and adrenergic re ceptors will also evoke increases in the secretion of cyclooxygenase products into the cerebral ven tricles and these effects are readily antagonized by nicotinic and adrenergic antagonists, respectively (Navarro et al., 1988) . These results further suggest the probable relevance of receptor-linked second messenger systems, the activation of which results in an increase in cytosolic free fatty acids.
Because the rate-limiting step of prostaglandin synthesis is the level of cytosolic arachidonic acid (Leslie and Watkins, 1985) , the generation of this fatty acid under normal conditions will give rise to a rapid increase in cyclooxygenase products. How ever, because the effects of cyclooxygenase are de pendent on molecular oxygen, the production of prostanoids during periods of cerebral ischemia and anoxia would be expected to be progressively dis sociated from the rise in free fatty acids. Consistent with the above, the present results demonstrate that after ischemia there is an increase in the levels of prostanoids, with the most marked elevation oc curring during the reflow period. These results are consistent with studies in which levels measured in brain showed relatively little increase in cyclooxy genase products during the ischemic interval and significant increases during the period after reflow Jacobs et al. , 1986; Kemski et al., 1987; Shohami et al., 1987) . In the present study, a mild increase in three of four prostanoids was observed during the ischemic event. We con sider this initial synthesis during the acute period of ischemia to reflect the progressive depletion of available oxygen during the developing anoxia. The marked increases in prostanoid levels after reflow may thus be most parsimoniously explained by the replenishment of O2 and the presence of abundant pools of free fatty acids. We believe the progressive return of prostanoid levels to near baseline levels during reflow reflects the progressive depletion of available free fatty acid pools. Importantly, during the period of reflow after 15-30 min of ischemia, the levels of brain free fatty acids have indeed been shown to fall precipitously within the first 5 min and are at or near preischemic levels by 30 min (Yoshida et al., 1986; Gardiner et al. , 1981; Rehn crona et al. , 1982) . The fact that the prostanoid levels, although falling, remain elevated during the 2-h postreflow phase may reflect on the clearance of a large pool of prostanoids formed during the ischemic/immediate postischemic phase or a con tinued free fatty acid production, for periods longer than previously reported (see above).
Correlation between prostaglandin secretion and physiologic outcomes
The physiologic effects of arachidonic metabo lites have varied and often opposing actions (Mon cada et al., 1980; Moskowitz and Coughlin, 1981; J Cereb Blood Flow Metab, Vol. 8, No.6, 1988 Pickard, 1981 . Many studies suggest that these metabolites, namely prostaglandins, Tx, and leuko trienes that accumulate in the brain during and after periods of ischemia may account for the cerebro vascular events as well as tissue damage observed (Moskowitz et al., 1984; Siesjo, 1981 Siesjo, , 1984 Sho hami et al., 1987) . It should also be noted that some prostanoids may be of benefit in recovery from a cerebral ischemic event. Thus, although Tx and PGF2a are vasoconstrictors and Tx is a potent platelet aggregator (Moncada et al., 1980; Mosko witz and Coughlin, 1981) , PGI2 (produced by vas cular endothelium) is a potent vasodilator, inhibits platelet aggregation, stabilizes cell membranes, and hinders the inflammatory response by inhibiting polymorphonuclear chemotaxis (Gryglewski et al., 1983; Hallenbeck and Furlow, 1979; Moncada, 1983; Moncada et aI. , 1980; Moskowitz and Coughlin, 1981) . It has been suggested that the"' overall response of cerebrovasculature as well as the degree of cerebral tissue damage is due to the shift in the balance of the opposing effects of ara chidonic acid metabolites, in particular Tx and 6keto (Moskowitz and Coughlin, 1981; Moncada and Vane, 1979; Shohami et al., 1987) . In a recent study of spinal cord ischemia in the rabbit, increased levels of thromboxane B2 correlated well with an increase in neurological dysfunction (Jacobs et al., 1986; Shohami et al. , 1987) . On the other hand, prostacyclin, a vasodilator and anti-platelet aggre gator, has been reported to improve the regional blood flow in the brain during the postischemic pe riod (Gryglewski et aI. , 1983; Hallenbeck and Furlow, 1979) .
Our data are in agreement with the above inter pretation. Thus, under resting conditions, the mea sured levels of 6-keto and Tx are comparable. However, after complete cerebral ischemia, Tx levels are preferentially elevated in the extravas cular-extracellular space as compared with 6-keto. The mechanism of this differential appearance is not known. Given that both forms measured are stable metabolites of the parent compound, it ap pears unlikely that these differences arise solely from an artifact of conversion. Because the kinetics of 6-keto and Tx have not to our knowledge been examined, it is possible that the elevated increase in Tx might reflect either a preferential influx or de layed clearance. If the source of 6-keto is in the vascular wall versus Tx in the platelet, the selective increase might be the result of an easier diffusional access to the CSF sink. Alternatively, both 6-keto and Tx show similar time courses of onset and in deed Tx shows its highest peak after 6-keto. These observations would argue against a simple diffu-sional barrier. Alternatively, endothelial damage re sUlting in the loss of prostacyclin synthetase ac tivity, as well as the buildup of hydroperoxides that inhibit prostacyclin synthetase (Shohami et aI. , 1987) , might occur and reduce the ability to synthe tize prostacyclin. Conversely, vascular damage and stagnation of CBF would favor platelet aggregation and Tx production. Such events would result in neuronal and further cerebrovascular injury, leading to poor EEG recovery, cerebral perfusion, and cerebrovascular responsiveness. We believe it may be significant that the increase in the Tx levels and Tx/6-keto ratios were highest in untreated an imals -30-60 min after reflow. Although this may be fortuitous, this period, in which a preponder ance of vasoconstrictive and platelet aggregative activity is highest, corresponds with the interval during reflow in this model, when the delayed hy poperfusion began to be significant and the EEG profile declined in our previous studies (Stevens et aI., 1986) .
Zomepirac sodium-pretreated animals showed marked reductions in levels of all measured pros tanoids before, during, and after 15 min of complete global ischemia, thereby validating its ability to in hibit the cerebral synthesis of prostaglandins. Tx was much more inhibited than 6-keto, suggesting that zomepirac sodium, like aspirin, may inhibit not only cyclooxygenase but also Tx synthetase, thereby inhibiting the production of Tx at two points along its synthetic pathway (Moncada and Vane, 1978, 1979) . In fact, in ZS pretreated an imals, the Tx/6-keto ratio suggested favored pro duction of prostacyclin throughout the experiment (Figure 3 ). It should be noted that this preferential inhibition of TxB2 by ZS is not likely a unique prop erty of this drug. Previous studies have shown that aspirin will also preferentially reduce TxB2 as com pared to PGI2 (Moncada and Vane, 1978) . This forms the presumed basis for the beneficial role of cyclooxygenase inhibitors in stroke-prone patients. In any case, this shift in favor of production of prostacyclin may in part be responsible for the little or no delayed hypoperfusion and therefore im proved EEG recovery of cyclooxygenase-induced animals after partial and complete ischemia that has been previously reported by several laboratories (Hallenbeck and Furlow, 1979; Kagstrom et aI. , 1983; Okabe et aI. , 1983; Shigeno et aI. , 1985; Stevens et aI., 1986) .
We note that although these studies support the probable relevance of the cyclooxygenase pathway in the sequelae of complete ischemia, they do not provide support for its unique contribution. Vir tually all of the current cyclooxygenase inhibitors may influence a variety of other functions (Pickard, 1981) . Thus, the lipooxygenase pathway, an impor tant alternate pathway employing free fatty acids as substrates, was not examined in these experiments. Obviously, studies on this limb of the pathways for arachidonic acid metabolism are important because products of lipooxygenase also have profound cere brovascular effects (Black, 1984; Feurstein, 1985) and are synthesized as a consequence of ischemia (Moskowitz et aI., 1984) .
